Dr. Nadia Kulagina has 13 years of experience in ligand binding assay development for large molecules and pathogens on various platforms (ELISA, ECL, RIA, Cell-based, Fluorescence, Luminex and microelectrode arrays). In her role as Associate Director, Dr. Kulagina is responsible for the scientific and technical administration of method development, validation and sample analysis studies. She is responsible for the interpretation, approval, documentation and reporting of study results and maintains close and regular liaison with clients. Prior to Smithers Avanza, she held the position of Senior Lead Principal Investigator at Covance Labs. Dr. Kulagina holds a Master of Science from Moscow State University, Russia, and PhD in Chemistry from University of Pittsburgh, Pittsburgh, PA. Dr. Kulagina has authored and co-authored 29 meeting presentation abstracts, and 22 publications, including one patent. Dr. Kulagina has participated in the preparation and submission of multiple grant proposals to the USDA, FDA, NOVA, DARPA, and NIH.